ASX:Live
Short Term
Mean Reversion
Neutral
Trend
Neutral
Event
Neutral
Halo Model
MQV
Very Strong
GARP
Very Strong
MQV Small
Neutral
Valuation
Value
Consensus
Momentum
Price
Very Strong
Earnings
Very Strong
Growth
Earnings
Very Strong
Dividends
Very Strong
Quality
Capital Efficiency
Very Strong
Balance Sheet
Very Strong
Description
Clever Culture Systems Ltd. engages in the business of researching, developing, and commercializing innovative technologies for healthcare and laboratory supply markets. It operates through the following geographical regions: Australia, Switzerland, the United States, Sweden, the United Kingdom, and Germany. The company was founded by Lusia Halina Guthrie, Douglas Peter LeMessurier, and Paul Andrew Mariani in 2004 and is headquartered in Adelaide, Australia.
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 0.01 - 0.03
Trade Value (12mth)
AU$8,075.00
1 week
-14.29%
1 month
-25%
YTD
-33.33%
1 year
-53.85%
All time high
0.76
EPS 3 yr Growth
-77.40%
EBITDA Margin
-358.40%
Operating Cashflow
-$4m
Free Cash Flow Return
-98.00%
ROIC
-99.80%
Interest Coverage
-11.60
Quick Ratio
2.60
Shares on Issue (Fully Dilluted)
2218m
HALO Sector
Healthcare
Next Company Report Date
27-Aug-25
Ex Dividend Date (est.)
N/A
Next Dividend Pay Date (est.)
N/A
Reporting Currency
AUD
Short Sell (% of issue)
0.00
| Date | Announcements |
|---|---|
|
21 February 25 |
Half Yearly Report and Accounts
×
Half Yearly Report and Accounts |
|
12 February 25 |
Application for quotation of securities - CC5
×
Application for quotation of securities - CC5 |
|
05 February 25 |
Application for quotation of securities - CC5
×
Application for quotation of securities - CC5 |
|
30 January 25 |
Quarterly Activities/Appendix 4C Cash Flow Report
×
Quarterly Activities/Appendix 4C Cash Flow Report |
|
15 January 25 |
Notification regarding unquoted securities - CC5
×
Notification regarding unquoted securities - CC5 |
|
15 January 25 |
Notification of cessation of securities - CC5
×
Notification of cessation of securities - CC5 |
|
14 January 25 |
Notification of cessation of securities - CC5
×
Notification of cessation of securities - CC5 |
|
10 January 25 |
Proposed issue of securities - CC5
×
Proposed issue of securities - CC5 |
|
03 January 25 |
Notification of cessation of securities - CC5
×
Notification of cessation of securities - CC5 |
|
03 January 25 |
Change of Director's Interest Notices
×
Change of Director's Interest Notices |
|
10 December 24 |
Notification regarding unquoted securities - CC5
×
Notification regarding unquoted securities - CC5 |
|
10 December 24 |
Notification regarding unquoted securities - CC5
×
Notification regarding unquoted securities - CC5 |
|
05 December 24 |
Additional Four Instruments Ordered by AstraZeneca
×
Additional Four Instruments Ordered by AstraZeneca |
|
05 December 24 |
Application for quotation of securities - CC5
×
Application for quotation of securities - CC5 |
|
03 December 24 |
Notification of cessation of securities - CC5
×
Notification of cessation of securities - CC5 |
Load More
Load Less
Ex Dividend Date (est.)
DIV Yield
Franking Level
DPSg
Quality Yield
Falling Divs over next 2
Consensus Score
Recommendation
EPS 1 month Change
Quality Yield
Falling Divs over next 2
Percent of Issue
Value ($M)
Prior Change
7 Day Change
1 Month Change
3 Month Change
Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.
Unlock true investor intelligence
Research, trade and manage global markets from one place with HALO Global. It’s trading - the way you want it.
.svg)
Get the latest insights and hot tips delivered right to your inbox
HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.
